USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
19 - 22 Oct 2025 | Las Vegas

Cracking the FDA Code

Keep exploring for FREE!

Create a free account or log in to unlock content, event past recordings and more!

Speakers:

Jason Bellet Co-founder and CBOEko
Jason Bellet
Co-founder and CBOEko
Kara Egan CEO & Co-FounderTeal Health
Kara Egan
CEO & Co-FounderTeal Health
Yeji Jesse Lee Senior healthcare reporterLaw360
Yeji Jesse Lee
Senior healthcare reporterLaw360

About this Session:

With drug development timelines averaging 10-15 years and costs soaring into the billions, navigating the FDA's labyrinthine review process has become the ultimate test of entrepreneurial endurance, scientific rigor, and investor loyalty. But some companies are actually cracking this code, and it's not just about having the deepest pockets or the best lawyers, it's about understanding that the FDA isn't your enemy, it's your extremely thorough, safety-obsessed business partner. The secret sauce lies in early engagement strategies, bulletproof trial design, and building relationships with regulatory teams who can guide you through the maze before you've burned through your entire Series B funding. From breakthrough therapy designations that can fast-track your timeline to common pitfalls that turn promising drugs into cautionary tales, there are fine-tuned strategies that separate the companies that successfully launch life-changing therapies and devices from those that become expensive lessons in what not to do.